Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wugen
Biotech
Wugen woos VCs, landing $115M to bring CAR-T therapy to market
Wugen is running a pivotal trial to support a 2027 FDA filing for what could be the first off-the-shelf CAR-T for T-cell malignancies.
Nick Paul Taylor
Aug 27, 2025 8:10am
Private equity firms take over bluebird's nest—Chutes & Ladders
Feb 28, 2025 8:30am
Flagship-backed biotechs name new leaders—Chutes & Ladders
Nov 15, 2024 8:30am
Former Seagen CEO takes on new role—Chutes & Ladders
Mar 24, 2023 9:30am
Wugen banks $172M for off-the-shelf cell therapies
Jul 15, 2021 7:00am
